Literature DB >> 14715450

Protective effects of nicotine on ethanol-induced toxicity in cultured cerebellar granule cells.

Yousef Tizabi1, Mashael Al-Namaeh, Kebreten F Manaye, Robert E Taylor.   

Abstract

Alcoholism is associated with a higher incidence of smoking. In addition to the stimulatory effects of both ethanol and nicotine on the mesolimbic reward pathway, nicotine's ability to counteract some of the adverse effects of ethanol (e.g. ataxia) may be a powerful incentive for alcohol consumers to increase their tobacco (nicotine) intake. The cerebellum is believed to play an important role in ethanol-induced ataxia. In this study, we sought to test the hypothesis that nicotine would protect against toxic effects of ethanol in primary cultures of cerebellar granule cells. Moreover, it was postulated that the effects of nicotine would be mediated through nicotinic receptors. Primary cultures of cerebellar granule cells were prepared from 20-day embryos obtained from timed-pregnant Sprague Dawley rats. Cells were cultured for 10 days and were then exposed for 3 days to various concentrations of ethanol with and without pretreatment with nicotine and nicotinic antagonists. Cellular toxicity was evaluated by measuring the lactate dehydrogenase level. Administration of ethanol (10-100 mM) resulted in a dose-dependent toxicity. Pretreatment with nicotine 1-20 micro M resulted in a dose-dependent protection against ethanol-induced toxicity. The effects of nicotine were blocked by pretreatment with nicotinic antagonists such as mecamylamine 1-20 micro M, dihydro-beta-erythroidine 1.0 nM-1.0 micro M and methyllycaconitine 5 nM-5 micro M in a dose-dependent manner. Thus, ethanol-induced cytotoxicity in primary cultures of cerebellar granule cells is blocked by pretreatment with nicotine. The effects of nicotine, in turn, may be blocked by nicotinic antagonists, implicating both high and low affinity nicotinic receptors in mediating the actions of nicotine. The exact mechanism of ethanol-induced toxicity and/or neuroprotection through activation of nicotinic receptors in this paradigm remains to be elucidated. The neuroprotective effect of nicotine against ethanol-induced toxicity in cerebellar neurons may be a contributing factor to the high incidence of smoking among alcoholics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14715450     DOI: 10.1007/bf03033151

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  48 in total

Review 1.  Central nicotinic receptors, neurotrophic factors and neuroprotection.

Authors:  N Belluardo; G Mudò; M Blum; K Fuxe
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

Review 2.  Brain nicotinic receptors: structure and regulation, role in learning and reinforcement.

Authors:  J P Changeux; D Bertrand; P J Corringer; S Dehaene; S Edelstein; C Léna; N Le Novère; L Marubio; M Picciotto; M Zoli
Journal:  Brain Res Brain Res Rev       Date:  1998-05

3.  Morphological and physiological properties of rat cerebellar neurons in mature and developing cultures.

Authors:  D L Gruol; C P Crimi
Journal:  Brain Res       Date:  1988-06-01       Impact factor: 3.252

4.  Codistribution of nicotinic acetylcholine receptor subunit alpha3 and beta4 mRNAs during rat brain development.

Authors:  U H Winzer-Serhan; F M Leslie
Journal:  J Comp Neurol       Date:  1997-10-06       Impact factor: 3.215

5.  Ethanol has differential effects on rat neuron and thymocyte reactive oxygen species levels and cell viability.

Authors:  M J Huentelman; C M Peters; W E Ervine; S M Polutnik; P Johnson
Journal:  Comp Biochem Physiol C Pharmacol Toxicol Endocrinol       Date:  1999-09

6.  Clinical correlates of cigarette smoking and nicotine dependence in alcohol-dependent men and women. The Collaborative Study Group on the Genetics of Alcoholism.

Authors:  J B Daeppen; T L Smith; G P Danko; L Gordon; N A Landi; J I Nurnberger; K K Bucholz; E Raimo; M A Schuckit
Journal:  Alcohol Alcohol       Date:  2000 Mar-Apr       Impact factor: 2.826

Review 7.  Nicotine and neurodegeneration in ageing.

Authors:  Alessio Zanardi; Giuseppina Leo; Giuseppe Biagini; Michele Zoli
Journal:  Toxicol Lett       Date:  2002-02-28       Impact factor: 4.372

8.  A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death.

Authors:  I Hajimohammadreza; A W Probert; L L Coughenour; S A Borosky; F W Marcoux; P A Boxer; K K Wang
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

Review 9.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

10.  Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries.

Authors:  Vincent Laudenbach; Fadia Medja; Michele Zoli; Francesco M Rossi; Philippe Evrard; Jean-Pierre Changeux; Pierre Gressens
Journal:  FASEB J       Date:  2002-01-14       Impact factor: 5.191

View more
  19 in total

Review 1.  Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.

Authors:  Laura L Hurley; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-09-20       Impact factor: 3.911

2.  Classifying neuronal subclasses of the cerebellum through constellation pharmacology.

Authors:  Kigen J Curtice; Lee S Leavitt; Kevin Chase; Shrinivasan Raghuraman; Martin P Horvath; Baldomero M Olivera; Russell W Teichert
Journal:  J Neurophysiol       Date:  2015-11-18       Impact factor: 2.714

3.  Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease.

Authors:  Robert L Copeland; Yaminah A Leggett; Yasmine M Kanaan; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

Review 4.  Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance.

Authors:  Merouane Bencherif
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

Review 5.  Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Authors:  S Chatterjee; S E Bartlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

6.  Toxic effects of low alcohol and nicotine combinations in SH-SY5Y cells are apoptotically mediated.

Authors:  Carlana Ramlochansingh; Robert E Taylor; Yousef Tizabi
Journal:  Neurotox Res       Date:  2011-01-08       Impact factor: 3.911

Review 7.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 8.  Neuroinflammation, neurodegeneration, and depression.

Authors:  Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2012-08-16       Impact factor: 3.911

Review 9.  Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

Review 10.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.